An entire population of adults has not been accounted for when it comes to administering COVID-19 vaccinations. Pregnant women, who are at higher risk of severe illness if they contract the virus, were excluded from vaccine clinical trials, and now there is debate and concern about whether or not they are safe for expecting mothers.
March of Dimes CEO Stacey Stewart said the exclusion of pregnant women in vaccine testing is an outdated process and a roadblock for the advancement of science.
"It's 2021, we need to take a more modern approach to how we advance science, especially as it relates to pregnant women [and] to newborn babies," Stewart told Cheddar. "At the March of Dimes, we've been a long advocate for newborn screening for all the things that would help us to make sure that moms and babies are protected,"
While the CDC and the World Health Organization both agree that patients should consult with a doctor to make the best decision for themselves and their baby, the impact of the vaccines, particularly the Moderna and Pfizer/BioNTech mRNA vaccines that do not use the live version of the virus, on pregnancies is unknown. So far, both companies are monitoring women who became pregnant after getting vaccinated.
According to Stewart, the fact that the Moderna and Pfizer's vaccines do not "influence or alter the DNA" signals that they would be a safe option for pregnant women to consider.
"What we are saying at the March of Dimes is consult your health care practitioner," she said. "But by all means, know that as a pregnant woman you are at potentially higher risk of severe illness if you contract COVID-19, so we would certainly recommend that women give serious thought to receiving the vaccine when they're able to."
Last week, NIAID Director Dr. Anthony Fauci said of the more than 10,000 pregnant women that have been vaccinated, no major incidents have been reported, which Stewart said is a good indicator of safety.
"If a woman is at high risk, is an essential worker, is at high risk of being in contact with someone that has COVID-19, is at high risk herself of severe illness because of comorbidities, please consider the vaccine because it could save your life. It could save the life of your baby as well," she noted.
Energy Vault, the company developing sustainable, grid-scale energy storage solutions, is now trading on the New York Stock Exchange following the completion of its business combination with Novus Capital Corporation II. Energy Vault develops sustainable, grid-scale energy storage solutions designed to advance the transition to a carbon free, resilient power grid. Robert Piconi, co-founder and CEO of Energy Vault, joins Cheddar News' Closing Bell to disucss.
In an effort to fight climate change several corporations have vowed to work to fight climate change by 2030. They say the goal is to reduce carbon emissions by 40% or even close to 100%. However, according to a new study, many of these companies are not actually practicing what they preach. Tom Egger, senior lecturer at Emeritus at the University of Wisconsin, joins Cheddar News to discuss more.
At-home medical labs company Getlabs raised $20 million in a Series A round, led by Emerson Collective and the Minderoo Foundation. Getlabs aims to be the boots-on-the-ground partner to telehealth. The company says more than 70% of medical decisions still require collecting diagnostic tests in person, and that it fills that void by delivering health care directly to their patients' homes. Founder & CEO of Getlabs Kyle Michelson joined Cheddar News' Closing Bell to discuss.
Kalle Marsal, Chief Operating Officer at PetDx, joins Cheddar Innovates to discuss how next-generation sequencing technology is being used to detect cancer in pets early.
On this episode of Cheddar Innovates: WALDO CEO breaks down why now is a good time to make eyecare a priority, and how they are democratizing access to eyecare for all; COO at PetDx explains how next-generation sequencing technology is being used to detect cancer in pets early; Cheddar gets a look at Curiosity Stream's 'Inside The Mind of a Con Artist.'
Shares of Canadian cannabis giant Canopy Growth surged after the company reported Q3 earnings Wednesday morning, with shares up more than 15 percent at the close of the day's trading session. Despite net revenue declining year-over-year, Canopy beat analyst expectations and has ramped up efforts to develop a "THC ecosystem' in the U.S. Canopy Growth's CEO, David Klein, joined Cheddar News' Closing Bell to discuss the report. He noted that its brands Storz & Bickel vaporizers and BioSteel beverages showed record growth.
The Central Park Conservancy announced last month it has partnered with the Yale School of the Environment and the New York City-based Natural Areas Conservancy to study the on-the-ground impacts of climate change on urban parks. Salmaan Khan, Director of Research and Special Projects at the Central Park Conservancy joins Cheddar Climate to explain what factors put this initiative into motion and what data his team will be looking to uncover.
Energy Impact Partners is a VC firm committed to helping the world move toward a more sustainable future. The tech-focused fund aims to reach $350 million for its Deep Decarbonization Frontier Fund,' which aims to support early-stage companies working on innovative solutions. Energy Impact Partners' Managing Director Andy Lubershane joined Cheddar Climate to discuss.
Mukul Bakhshi, Chief of Strategy and Government Affairs for CGFNS International, joins Cheddar News to discuss strained U.S. hospitals seeking foreign nurses.
The Democratic governors of New Jersey, Connecticut, Delaware, and Oregon say they will lift mask requirements for schools in the coming weeks, reflecting a nationwide shift away from restrictions. Cheddar News speaks with internist Dr. Vivek Cherian whether it's safe to relax the regulation.
